Mineralocorticoid receptor antagonists in diabetic kidney disease—Mechanistic and therapeutic effects

J Barrera-Chimal, I Lima-Posada, GL Bakris… - Nature Reviews …, 2022 - nature.com
Chronic kidney disease (CKD) is the leading complication in type 2 diabetes (T2D) and
current therapies that limit CKD progression and the development of cardiovascular disease …

[HTML][HTML] Oxidative stress: a unifying paradigm in hypertension

RM Touyz, FJ Rios, R Alves-Lopes, KB Neves… - Canadian journal of …, 2020 - Elsevier
The etiology of hypertension involves complex interactions among genetic, environmental,
and pathophysiologic factors that influence many regulatory systems. Hypertension is …

Aldosterone, inflammation, immune system, and hypertension

NS Ferreira, RC Tostes, P Paradis… - American journal of …, 2021 - academic.oup.com
Aldosterone is a mineralocorticoid hormone that controls body fluid and electrolyte balance.
Excess aldosterone is associated with cardiovascular and metabolic diseases. Inflammation …

Roles of mineralocorticoid receptors in cardiovascular and cardiorenal diseases

J Barrera-Chimal, B Bonnard… - Annual Review of …, 2022 - annualreviews.org
Mineralocorticoid receptor (MR) activation in the heart and vessels leads to pathological
effects, such as excessive extracellular matrix accumulation, oxidative stress, and sustained …

Alterations in endothelial nitric oxide synthase activity and their relevance to blood pressure

T Suvorava, S Metry, S Pick, G Kojda - Biochemical pharmacology, 2022 - Elsevier
Among all physiologic functions of nitric oxide (NO) known so far, NO-dependent regulation
of vascular tone is one of the most important. Under physiological conditions vascular NO is …

NLRP3 inflammasome and mineralocorticoid receptors are associated with vascular dysfunction in type 2 diabetes mellitus

NS Ferreira, T Bruder-Nascimento, CA Pereira… - Cells, 2019 - mdpi.com
Aldosterone excess aggravates endothelial dysfunction in diabetes and hypertension by
promoting the increased generation of reactive oxygen species, inflammation, and insulin …

The regulation of aldosterone secretion by leptin: implications in obesity-related cardiovascular disease

JL Faulkner, T Bruder-Nascimento… - Current opinion in …, 2018 - journals.lww.com
The regulation of aldosterone secretion by leptin: implicati... : Current Opinion in
Nephrology and Hypertension The regulation of aldosterone secretion by leptin …

Involvement of vascular aldosterone synthase in phosphate-induced osteogenic transformation of vascular smooth muscle cells

I Alesutan, J Voelkl, M Feger, DV Kratschmar… - Scientific reports, 2017 - nature.com
Vascular calcification resulting from hyperphosphatemia is a major determinant of mortality
in chronic kidney disease (CKD). Vascular calcification is driven by aldosterone-sensitive …

The effect of aldosterone and aldosterone blockade on the progression of chronic kidney disease: a randomized placebo-controlled clinical trial

H Minakuchi, S Wakino, H Urai, A Kurokochi… - Scientific reports, 2020 - nature.com
The progression of chronic kidney disease (CKD) cannot be completely inhibited. We first
explored factors contributing to CKD progression in patients with CKD in a prospective …

Circadian variation of blood pressure in patients with chronic musculoskeletal pain: a cross-sectional study

S Navarro-Ledesma, A Gonzalez-Muñoz… - International Journal of …, 2022 - mdpi.com
The aim of this study was to analyze the impact of circadian variation of blood pressure (BP)
in patients with chronic musculoskeletal pain (CPM). A further purpose was to study …